BioSpace News Archive

InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announces it will report fiscal second quarter 2020 financial results on Wednesday, August 5, 2020 at 8:00 AM ET. Management will host a conference call at 8:30AM ET, to review financial results and provide an update on corporate developments. Following management’s fo

Desmoid Tumor Program to Provide Springboard for Iterion to Initiate Additional Clinical Trials of Tegavivint in AML, Non-Small Cell Lung Cancer and Certain Pediatric Cancers

Varex Imaging Corporation (Nasdaq: VREX) today announced that effective July 27, 2020, Shubham “Sam” Maheshwari has joined Varex as its Chief Financial Officer (CFO), where he will lead the company’s finance and information technology organizations. “We are excited to have Sam join the Varex team,” said Sunny Sanyal, President and Chief Executive Officer of Varex. “Sam brings to Varex more than 20 years of experience

Company continues to prepare its lead product candidate, PRP, for a Phase IB, First-In-Human study, in advanced cancer patients suffering from solid tumors

Phase 1 Trial for the Treatment of Patients with Acute Lung Injury Due to COVID 19 Anticipated to Begin in Third Quarter of 2020

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that its prophylactic breast cancer vaccine is making progress towards clinical trials.

Paper supports use of nVNS as a front-line therapy for acute and preventative treatment of cluster headache and as an effective option for the treatment of migraine headache

Ibex Medical Analytics, the pioneer in artificial intelligence (AI)-powered cancer diagnostics, today announced outstanding outcomes in a clinical validation study for the first and only AI-based solution used by pathologists in routine clinical practice.

Sun Genomics, the direct-to-consumer personalized probiotics and gut health company, announced today the launch of Floré Defense: a custom blend of prebiotics, probiotics, and herbal supplements designed for the gut-lung microbiome axis and maintaining the body’s natural immune response to potential respiratory infection.

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless cervical cancer detection test based on its patented biophotonic technology, announced today that it had submitted its protocol to FDA for a clinical study to support marketing of the LuViva® Advanced Cervical Scan in the United States. Under FDA’s Investigational Device Exemption guidelines, the Agency typically responds to companies